BETA

IPO registrations (S-1, F-1) · Registrants

XTL BIOPHARMACEUTICALS LTD

SEC CIK
1023549 · filings on EDGAR ↗
Registration
Form F-1, first filed 2006-04-21, last 2018-02-28; 2 initial registrations, 3 amendments
Outcome
Declared effective 2006-05-22
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
L3
Business address
XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, New York, NY 10016
Ticker
XTLB (Nasdaq)
EDGAR entity type
other
Insiders and CEO pay
XTL BIOPHARMACEUTICALS LTD on the corporate pages

Filings 11

FiledFormWhat it isName as filedEDGAR
2006-04-21F-1F-1 (foreign registration)XTL BIOPHARMACEUTICALS LTD0001144204-06-016234 ↗
2006-05-22EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-06-000026 ↗
2007-03-28EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-07-001062 ↗
2007-11-20EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-07-004577 ↗
2008-09-11EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-08-002789 ↗
2014-04-04EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-14-000885 ↗
2015-12-31F-1F-1 (foreign registration)XTL BIOPHARMACEUTICALS LTD0001144204-15-073635 ↗
2016-11-08F-1/AF-1/A (amendment)XTL BIOPHARMACEUTICALS LTD0001144204-16-132216 ↗
2018-02-01F-1/AF-1/A (amendment)XTL BIOPHARMACEUTICALS LTD0001144204-18-005222 ↗
2018-02-28F-1/AF-1/A (amendment)XTL BIOPHARMACEUTICALS LTD0001144204-18-011743 ↗
2018-03-06EFFECTEFFECT (declared effective)XTL BIOPHARMACEUTICALS LTD9999999995-18-000533 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2018-02-01F-1/Aregistration statement$4.103,850,000$15,785,000Nasdaq XTLB0primary document; price line, shares headline, proceeds computeddocument ↗
2018-02-28F-1/Aregistration statement--0primary document; no terms founddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BENTSUR RONOfficerCEO32006–2007
Kessler WilliamOfficerDirector of Finance12007
Bradley ScottTenPercentOwner342007–2008
Cho MichaelTenPercentOwner342007–2008
EDELMAN JOSEPHTenPercentOwner352007–2008
PERCEPTIVE ADVISORS LLCTenPercentOwner352007–2008
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDTenPercentOwner352007–2008
WEISS MICHAEL SDirector22008
WEINER BEN-ZIONDirector22008
GOOD JENNIFER LDirector12008
KENNEDY WILLIAM JAMESDirector12008
Rudman SamuelDirector12008
ZUERBLIS KENNETH JDirector12008
Hillel Fain OsnatDirector12026
Segal NivOther12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-03-29XTL BIOPHARMACEUTICALS LTDPharmaceuticals$2,800,000$2,800,000221
2017-03-01XTL BIOPHARMACEUTICALS LTDPharmaceuticals$2,500,000$2,500,00051

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerXTL BIOPHARMACEUTICALS LTDForm D private offeringsCIK (EXACT)
SEC filerXTL BIOPHARMACEUTICALS LTDSEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Interests: Pharmaceutical Preparations · Health